drugset / Trial / NCT00838682
Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers
Phase 4
Terminated
106 enrolled
The Catholic University of Korea
Janssen Korea, Ltd., Korea · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is conducted to compare and evaluate the effect of administering a high-dose intravenous proton pump inhibitors or high-dose oral Rabeprazole in preventing recurrent bleeding after the endoscopic treatment of bleeding peptic ulcers.
Timeline
- Start
- 2006-04
- Primary completion
- 2009-01
- Completion
- 2009-03
Outcome
Met primary endpoint
Stopped (Enrollment): “Terminated before the complete enrollment due to slow enrollment”
registry NUMBER Omeprazole: 1 participants NCT00838682 ↗
registry analysis (superiority or other test); Rabeprazole Sodium vs Omeprazole; p <0.05; Fisher Exact NCT00838682 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Omeprazole | Other / unclassified | 8 mg | Intravenous |
| Subject | Rabeprazole | Small molecule | 10 mg | Oral |